ARPP21
Basic information
Region (hg38): 3:35638945-35794496
Links
Phenotypes
GenCC
Source:
- amyotrophic lateral sclerosis (Limited), mode of inheritance: AD
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ARPP21 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 32 | 33 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 32 | 3 | 0 |
Variants in ARPP21
This is a list of pathogenic ClinVar variants found in the ARPP21 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-35681854-G-T | not specified | Uncertain significance (Sep 22, 2023) | ||
3-35687748-C-G | not specified | Uncertain significance (Jan 22, 2024) | ||
3-35687757-C-A | not specified | Uncertain significance (Nov 08, 2022) | ||
3-35687797-G-A | Uncertain significance (Jun 01, 2023) | |||
3-35690130-G-A | not specified | Uncertain significance (Feb 23, 2023) | ||
3-35690935-T-C | not specified | Uncertain significance (Jan 26, 2022) | ||
3-35690984-A-G | not specified | Uncertain significance (Oct 03, 2022) | ||
3-35690990-C-A | not specified | Uncertain significance (Dec 08, 2021) | ||
3-35706991-G-C | not specified | Uncertain significance (Mar 30, 2024) | ||
3-35707034-G-A | not specified | Likely benign (Mar 30, 2024) | ||
3-35708980-G-C | not specified | Uncertain significance (Mar 20, 2023) | ||
3-35715459-C-G | not specified | Uncertain significance (Apr 06, 2022) | ||
3-35717300-G-A | not specified | Uncertain significance (Oct 29, 2021) | ||
3-35717327-A-G | not specified | Uncertain significance (Mar 25, 2024) | ||
3-35717352-C-G | Likely benign (Feb 01, 2023) | |||
3-35721618-G-C | not specified | Uncertain significance (Feb 26, 2024) | ||
3-35721633-T-A | not specified | Uncertain significance (Nov 17, 2022) | ||
3-35721637-G-A | not specified | Uncertain significance (Oct 17, 2023) | ||
3-35729327-G-A | not specified | Uncertain significance (Aug 08, 2023) | ||
3-35729375-C-T | not specified | Uncertain significance (Nov 22, 2021) | ||
3-35729395-G-A | not specified | Uncertain significance (Oct 02, 2023) | ||
3-35729404-C-G | not specified | Uncertain significance (Dec 08, 2022) | ||
3-35729427-G-C | not specified | Uncertain significance (Jul 22, 2022) | ||
3-35729430-T-A | not specified | Uncertain significance (Mar 01, 2024) | ||
3-35729432-G-T | Malignant tumor of prostate | Uncertain significance (-) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ARPP21 | protein_coding | protein_coding | ENST00000458225 | 18 | 155552 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0120 | 0.988 | 125710 | 0 | 38 | 125748 | 0.000151 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.261 | 432 | 448 | 0.965 | 0.0000231 | 5302 |
Missense in Polyphen | 88 | 116.54 | 0.75513 | 1407 | ||
Synonymous | 0.832 | 158 | 172 | 0.919 | 0.00000990 | 1571 |
Loss of Function | 4.60 | 13 | 47.1 | 0.276 | 0.00000232 | 507 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000889 | 0.000887 |
Ashkenazi Jewish | 0.0000997 | 0.0000992 |
East Asian | 0.000275 | 0.000272 |
Finnish | 0.000139 | 0.000139 |
European (Non-Finnish) | 0.0000887 | 0.0000879 |
Middle Eastern | 0.000275 | 0.000272 |
South Asian | 0.000102 | 0.0000980 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Isoform 2 may act as a competitive inhibitor of calmodulin-dependent enzymes such as calcineurin in neurons. {ECO:0000250}.;
Intolerance Scores
- loftool
- 0.354
- rvis_EVS
- -0.18
- rvis_percentile_EVS
- 40.56
Haploinsufficiency Scores
- pHI
- hipred
- Y
- hipred_score
- 0.552
- ghis
- 0.480
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.114
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Arpp21
- Phenotype
- nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Gene ontology
- Biological process
- biological_process;cellular response to heat
- Cellular component
- cellular_component;cytoplasm
- Molecular function
- molecular_function;nucleic acid binding;calmodulin binding